Your session is about to expire
← Back to Search
Decision-Making Support Tools for Prostate Cancer
Study Summary
This trial will study how to best support patients in making decisions about precision oncology treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an upcoming appointment to discuss genetic or tumor testing and targeted therapy.I understand and can follow the study's procedures.My prostate cancer is advanced, spread to lymph nodes, or resistant to hormone therapy.You can read and understand a document that explains the study, and you are willing to sign it.You are able to give your agreement by speaking.I have someone who helps with my care and they're willing to join interviews.You can speak and understand English.I meet the initial requirements to be considered for the study.I am 18 years old or older.You can speak, read, and understand English.
- Group 1: CLOSED TO ENROLLMENT: Stage 1 & 2: Patients, Caregivers, Providers
- Group 2: Stage 3: Patients, Caregivers using developed GA platform
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum number of patients that can be a part of this clinical trial?
"That is correct. The clinical trial, which was posted on May 12th, 2022, is currently looking for 117 patients to enroll at 1 location."
Are there any available vacancies for participants in this experiment?
"That is correct, the online information does show that the trial is still recruiting patients. The posting date was May 12th, 2022 and the most recent update was June 22nd, 2022. There is a total need for 117 individuals across one location."
What is the goal of this research?
"The primary outcome of this trial, which will be measured over a 6 months time frame is to Proportion of participants with a total score of >37.5 on the DCS. Secondary outcomes include Proportion of participants with correct responses on germline testing knowledge scale which is defined as The germline testing knowledge scale is a 16 item survey where participants response with an agree or disagree to each item addressing information they have received regarding germline testing. The proportion of participants who correctly responded to each knowledge item and 95% CI for each knowledge item will be reported., Proportion of providers who responded to yes for pre-test germline"
Share this study with friends
Copy Link
Messenger